---
title: "Legionella genetics: strains, sequence typing and source tracking"
source_url: https://legionella.io/articles/legionella-genetics-strains-sequence-typing-and-source-tracking/
canonical_url: https://legionella.io/articles/legionella-genetics-strains-sequence-typing-and-source-tracking/
pillar: "Legionella Basics & Science"
summary: "How sequence typing links a Legionnaires' case to a building, why most cases are never typed, and what that means for a UK duty holder's sampling decisions."
primary_keyword: "Legionella genetics"
date_published: 2025-11-10
date_reviewed: 2026-06-26
author: "Legionella.io editorial team (REMOTE TECH LTD)"
reviewed_against: "HSE L8 and HSG274 guidance"
region: "United Kingdom"
license: "(c) REMOTE TECH LTD. Quote freely with attribution and a link to source_url."
---

# Legionella genetics: strains, sequence typing and source tracking

Strain typing almost never changes what you do on Monday morning. It changes everything on the worst day: the one where a public health team is working out whether your building put someone in hospital. By then the genetics either works in your favour or it cannot be done at all, and which of those is true was settled weeks before anyone phoned you.

Knowing the species sitting in your calorifier is not really the point. The point is discrimination. Can a laboratory show that the Legionella in your water is the same organism that grew in a patient's lungs, or a clearly different one? That single comparison is what links a case to a source, and it is the spine of every outbreak investigation.

## From species to fingerprint: what strain typing measures

Typing is a ladder of increasing resolution, and each rung narrows the field.

At the top is the broad question of species. *Legionella pneumophila* causes most Legionnaires' disease, though dozens of other species exist and a minority cause illness too [6]. Below that sits the serogroup. *L. pneumophila* serogroup 1 is the one most associated with confirmed human cases, which matters enormously for source tracking and is worth flagging up front: the standard urinary antigen test diagnoses cases largely by detecting serogroup 1 antigen [1].

Finer still are the methods that actually fingerprint an organism. Monoclonal antibody subgrouping splits serogroup 1 into recognisable subtypes. Sequence-based typing (SBT) reads the DNA sequence at a defined set of genes and reduces it to a sequence type, a kind of barcode you can compare between samples. Whole genome sequencing (WGS) goes further again, comparing organisms down to individual genetic differences and resolving strains that SBT would call identical [1].

The practical reading of that ladder: "we found *Legionella*" tells an investigator almost nothing about attribution. "We found this specific sequence type, indistinguishable from the patient's" tells them a great deal.

## Why most cases never get typed

Here is the part generic explainers skip. To climb that ladder, you need a living organism to test, and most cases never produce one on the clinical side.

The urinary antigen test is fast, cheap and the workhorse of diagnosis, but it detects a marker, not a microbe. It confirms infection while leaving nothing to sequence [1]. Getting a typeable clinical isolate means culturing the bacterium from a respiratory sample, and many patients cannot produce good sputum or have already started antibiotics by the time anyone asks. So a large share of confirmed cases arrive at the investigation with no isolate at all.

The same trap exists on your side of the fence. A PCR result tells you *Legionella* DNA is present in a sample; it does not hand you an organism to fingerprint. If your sampling regime relies on PCR alone, and a case is later linked to your premises by location, you may have nothing to put on the comparison table. Culture-based sampling, taken and handled to the appropriate standard, is what preserves that option [3][4]. This is the quiet, load-bearing decision, and it is made long before any outbreak: the time to secure a culturable isolate is during routine and investigative sampling, not after the phone rings.

## How investigators match a case to a water system

Picture the comparison as two columns feeding a single decision point. Sketch it and the logic becomes obvious.

The left column is clinical. Patient, to respiratory sample, to culture, to a clinical isolate, to the typing ladder: serogroup, then SBT, then WGS.

The right column is environmental. Suspected building or buildings, to water samples, to culture, to environmental isolates, run up the *same* typing ladder so the two can be compared like with like.

Those columns meet at a matching node, and it has three outputs, not two. **Indistinguishable** strains are strong supporting evidence that the building is the source. **Clearly different** strains effectively exclude that water system for that case, which is the under-appreciated upside of the science: typing can clear you, not only implicate you. The third output is the common one. **No clinical isolate, or no environmental isolate**, means there is simply nothing to compare, and the link stays unproven either way.

Two qualifiers sit over the whole diagram. First, an epidemiological overlay: was the patient plausibly exposed to that water during the incubation window? Genetics and exposure history are read together, never genetics alone. Second, the same sequence type can turn up in unrelated buildings, so a match is powerful corroboration rather than a sole verdict [2]. UKHSA's investigation framework treats microbiological matching as one strand of evidence woven with case-finding and environmental assessment.

## What this changes on your site

For a duty holder, three things follow, and none of them is "commission genome sequencing".

Sample so that evidence can exist. Where your risk assessment calls for sampling, getting a culturable result rather than DNA-only keeps the door open to typing if you ever need to be ruled in or out [3][4]. A documented history of clean cultures is also the kind of evidence that helps exclude a system early.

Resist the harmless-strain trap. It is tempting to reason that your environmental *Legionella* is "probably not the dangerous one" and ease off. Don't. You control to the counts, temperatures and conditions set out through your risk assessment, and the required actions at a given count do not wait on a strain type [5]. Typing is retrospective and carried out by others; it is not a live control measure and it is certainly not an excuse.

Understand what a match does and does not mean, in both directions. A genetic match between a patient and your water is serious supporting evidence, but attribution still weighs exposure and the possibility of other sources. Equally, a clean mismatch can take your building out of the frame. Both depend entirely on isolates existing in the first place, which loops straight back to how you sample. If you want the groundwork, [Legionella sampling 101: how and why to test your water](https://legionella.io/articles/legionella-sampling-101-how-and-why-to-test-your-water/) covers why and how to test, and [Public health tracking: how Legionella outbreaks are investigated](https://legionella.io/articles/public-health-tracking-how-legionella-outbreaks-are-investigated/) walks through how an investigation actually unfolds.

## A note on certainty

This is background to sharpen your sampling and record-keeping decisions, not a laboratory protocol and not a basis for diagnosing or attributing any illness. Strain typing and source attribution are done by accredited laboratories and public health teams who interpret them with full context; a duty holder neither runs nor adjudicates them. What you genuinely control is whether usable evidence exists when it is needed, and whether your everyday counts, temperatures and conditions stand up to scrutiny regardless of which strain is present.

## FAQ

### Does finding L. pneumophila serogroup 1 in our water mean we caused a case?
No. Presence is not attribution. A link requires a patient with a culturable isolate, a matching environmental isolate from your system, and plausible exposure during the incubation period. Detection on its own tells you to act on control, not that you are the source of any particular illness.

### Should we routinely commission whole genome sequencing on our samples?
Generally no. WGS is an investigation and research tool, not a routine compliance measure, and you would not normally pay for it on standard samples. The useful move is more modest: where your risk assessment calls for sampling, make sure it can yield a culturable isolate so that typing is possible if an investigation ever needs it.

### If a patient's strain matches ours, are we automatically liable?
A match is strong evidence linking your system to the case, but it is one strand among several. Investigators still consider exposure, timing and whether other premises share the same strain. It also cuts the other way: a clear mismatch can exclude your building. Liability is a legal judgement made on the whole picture, not on the typing result alone.

## Related reading

- [Public health tracking: how Legionella outbreaks are investigated](https://legionella.io/articles/public-health-tracking-how-legionella-outbreaks-are-investigated/)
- [Reporting Legionnaires' disease: RIDDOR, public health and incident escalation](https://legionella.io/articles/reporting-legionnaires-disease-riddor-public-health-and-incident-escalation/)
- [Legionella sampling 101: how and why to test your water](https://legionella.io/articles/legionella-sampling-101-how-and-why-to-test-your-water/)
- [Advances in Legionella research and studies](https://legionella.io/articles/advances-in-legionella-research-and-studies/)

## Sources

[1] CDC, "Laboratory Testing for Legionella". https://www.cdc.gov/legionella/php/laboratories/index.html
[2] UKHSA, "Investigation of Legionnaires' disease: cases, clusters and outbreaks". https://www.gov.uk/government/publications/investigation-of-legionnaires-disease-cases-clusters-and-outbreaks
[3] HSE, "Testing and monitoring your water system for legionella". https://www.hse.gov.uk/legionnaires/testing-monitoring-water-system.htm
[4] BSI, "BS 7592:2022 - Sampling for Legionella bacteria in water systems. Code of practice". https://knowledge.bsigroup.com/products/bs-7592-sampling-for-i-legionella-i-bacteria-in-water-systems-code-of-practice-1
[5] HSE, "Legionnaires' disease: Technical guidance (HSG274)". https://www.hse.gov.uk/pubns/books/hsg274.htm
[6] CDC, "About Legionnaires' Disease". https://www.cdc.gov/legionella/about/index.html